Pacemakers

Introduction

Pacemaker: implantable device delivering electrical impulses to heart muscle to maintain adequate heart rate. First implanted: 1958 (Arne Larsson, Stockholm). Current: >1 million implanted annually worldwide. Evolution: from fixed-rate devices to adaptive, multi-chamber, rate-responsive systems. Impact: transforms quality of life for patients with bradycardia, heart block, and selected heart failure cases.

"The pacemaker is one of medicine's greatest engineering achievements. A device smaller than a matchbox sustains life for a decade, sensing the heart's electrical activity and responding within milliseconds when needed." -- Cardiac electrophysiologist

Cardiac Conduction System

Normal Pathway

SA node (sinoatrial): natural pacemaker, generates impulse (60-100 bpm). AV node (atrioventricular): delays signal (~120-200 ms, allows atrial filling). Bundle of His: transmits to ventricles. Bundle branches: left and right, divide signal. Purkinje fibers: rapid distribution throughout ventricles.

ECG Correlation

P wave: atrial depolarization (SA node fires). PR interval: AV node conduction delay (120-200 ms normal). QRS complex: ventricular depolarization (< 120 ms normal). T wave: ventricular repolarization. Abnormalities: prolonged PR = AV block, wide QRS = bundle branch block.

Conduction Disorders

Sick sinus syndrome: SA node dysfunction (bradycardia, pauses). First-degree AV block: prolonged PR > 200 ms (usually benign). Second-degree AV block: intermittent dropped QRS (Mobitz I vs. II). Third-degree (complete) AV block: no AV conduction (ventricular escape rhythm 20-40 bpm). Consequence: inadequate cardiac output, syncope, death if untreated.

Indications for Pacing

Bradycardia

Symptomatic sinus bradycardia: heart rate < 60 bpm with symptoms (dizziness, fatigue, syncope). Chronotropic incompetence: heart rate fails to increase with exercise. Sinus pauses: > 3 seconds (risk of syncope). Class I indication: clear benefit from pacing.

AV Block

Third-degree block: always requires pacing (life-threatening). Second-degree Mobitz II: high risk of progression to complete block. Second-degree Mobitz I: pacing if symptomatic. First-degree: rarely requires pacing (unless extreme PR prolongation).

Heart Failure (CRT)

Cardiac resynchronization therapy: biventricular pacing for dyssynchrony. Indication: LVEF ≤ 35%, QRS ≥ 150 ms, NYHA class II-IV. Benefit: improved ejection fraction, reduced hospitalizations, survival benefit. Mechanism: synchronizes left and right ventricle contraction.

Neurocardiogenic Syncope

Vasovagal syncope: reflex-mediated bradycardia/hypotension. Pacing: controversial (limited evidence of benefit). Indication: severe, recurrent, with documented cardioinhibitory response. Rate-drop response: pacemaker detects sudden rate drop, paces temporarily.

Pacemaker Components

System Overview

Pulse generator: battery + electronics (hermetically sealed titanium case). Leads: insulated wires connecting generator to heart. Header: connector block linking leads to generator. Programming: wireless telemetry (in-office programmer). Total weight: 20-30 grams.

Battery

Chemistry: lithium-iodine (most common), lithium-carbon monofluoride. Capacity: 1-2 Ah. Voltage: 2.8 V (beginning of life), decreasing over time. Longevity: 8-15 years (depends on pacing burden, output settings). End-of-life indicator: voltage drop triggers elective replacement indicator (ERI).

Electronics

Microprocessor: controls sensing, pacing logic, rate response. Memory: stores ECG data, arrhythmia episodes, diagnostics. Output circuit: generates pacing pulses (voltage/current controlled). Sensing amplifier: detects cardiac signals (0.5-20 mV). Telemetry: wireless communication with external programmer.

Enclosure

Material: titanium (biocompatible, corrosion-resistant). Hermetic seal: prevents body fluid ingress (welded). Size: ~40 × 45 × 6 mm (credit card size, thinner). Weight: 20-30 grams. Connector: IS-1/IS-4 standard (interchangeable between manufacturers).

Lead Design and Placement

Lead Structure

Conductor: coiled or cable configuration (flexibility + fracture resistance). Insulation: silicone or polyurethane (biocompatible, durable). Electrode tip: steroid-eluting (reduces inflammation, lowers threshold). Fixation: passive (tines hook into trabeculae) or active (helix screws into myocardium). Diameter: 4-7 French (1.3-2.3 mm).

Placement Sites

Right atrial appendage: standard atrial lead position. Right ventricular apex: traditional ventricular lead position. Right ventricular septum: alternative (may preserve function better). His bundle: physiologic pacing (preserves native conduction). Left ventricular (CRT): coronary sinus tributary (epicardial).

Electrical Parameters

Lead Complications

Dislodgement: lead moves from original position (early complication, ~2-3%). Fracture: conductor breaks (late complication, especially subclavian crush). Insulation failure: exposed conductor causes short circuit. Infection: along lead tract (may require extraction). Perforation: lead tip penetrates through heart wall (rare, serious).

Pulse Generator

Output Parameters

Amplitude: voltage delivered (0.5-7.5 V, typically 2.5 V). Pulse width: duration (0.03-1.5 ms, typically 0.4 ms). Energy: amplitude² × pulse width / impedance. Safety margin: output set 2-3x above threshold (ensures capture). Automatic threshold management: device adjusts output to minimize energy use.

Capture Verification

Evoked response: electrical signal confirming myocardial depolarization. Autocapture: automatic threshold testing (adjusts output). Loss of capture: pacing spike without QRS (ineffective pacing). Clinical: backup safety pulse if primary fails to capture.

Rate Response

Sensors: accelerometer (most common, detects body motion). Minute ventilation: measures respiratory rate (impedance changes). Dual sensor: combines accelerometer + MV (more physiologic). Algorithm: maps sensor input to appropriate heart rate increase. Benefit: heart rate rises with activity (improves exercise tolerance).

Battery Monitoring

Beginning of life (BOL): full voltage, full capability. Elective replacement indicator (ERI): voltage dropped, replace within months. End of life (EOL): minimal function, emergency replacement. Monitoring: battery status checked at follow-up visits. Longevity prediction: algorithm estimates remaining battery life.

Pacing Modes

NBG Code

Position I: Chamber paced (A=atrium, V=ventricle, D=dual)Position II: Chamber sensed (A, V, D, O=none)Position III: Response to sensing (I=inhibit, T=trigger, D=dual)Position IV: Rate response (R=rate responsive, O=none)Position V: Multisite pacing (rarely used)

Common Modes

VVI: ventricular pacing, ventricular sensing, inhibited (simplest). AAI: atrial pacing, atrial sensing, inhibited (intact AV conduction). DDD: dual-chamber pacing and sensing (most versatile). DDDR: DDD with rate response (most common modern mode). VDD: ventricular pacing, dual sensing (single-lead dual chamber).

Mode Selection

Sinus node disease: AAI(R) if AV conduction intact, DDD(R) if questionable. AV block: DDD(R) preserves AV synchrony. Permanent atrial fibrillation: VVI(R) only (no atrial tracking possible). Heart failure (CRT): DDD-BiV (biventricular pacing). Principle: maintain AV synchrony when possible.

Mode Switching

Problem: atrial fibrillation causes rapid ventricular pacing in DDD mode. Solution: automatic mode switch to DDI or VVI during atrial tachyarrhythmia. Detection: atrial rate exceeds threshold (e.g., >170 bpm). Return: switches back when atrial rate normalizes. Clinical: prevents inappropriate rapid pacing.

Sensing and Detection Algorithms

Intracardiac Electrogram (EGM)

Signal: electrical activity recorded by lead electrodes. Amplitude: atrial P wave ~1-5 mV, ventricular R wave ~5-25 mV. Morphology: analyzed for discrimination (intrinsic vs. paced, normal vs. abnormal). Storage: device records episodes for later review.

Sensitivity Settings

Definition: minimum signal amplitude detected. Lower number = more sensitive (detects smaller signals). Over-sensing: detects noise as cardiac signal (inhibits pacing inappropriately). Under-sensing: misses cardiac signal (paces when shouldn't). Adjustment: balance between over- and under-sensing.

Noise Discrimination

Sources: electromagnetic interference (EMI), myopotentials, lead fracture. Blanking period: ignores signals immediately after pacing (prevents cross-talk). Refractory period: extended window ignoring T waves. Noise reversion: switches to asynchronous pacing if excessive noise detected.

Arrhythmia Detection

Rate criteria: atrial/ventricular rates above threshold. Stability: regular vs. irregular intervals (discriminate AF from VT). Morphology: compare EGM shape to stored template. Onset: sudden vs. gradual rate increase. Application: trigger mode switching, store diagnostic data.

Implantation Procedure

Surgical Approach

Access: subclavian or cephalic vein (left or right side). Lead insertion: fluoroscopy-guided through vein to heart. Testing: measure threshold, sensing, impedance at implant. Pocket: subcutaneous pocket below clavicle for generator. Duration: 1-2 hours (single chamber), 2-3 hours (dual/CRT).

Anesthesia and Preparation

Local anesthesia: conscious sedation (most common). General anesthesia: for CRT or complex cases. Sterile technique: infection prevention critical. Antibiotics: prophylactic dose pre-procedure. Imaging: fluoroscopy throughout (radiation exposure managed).

Post-Implant Care

Monitoring: 24-48 hours post-implant observation. Chest X-ray: confirm lead position, rule out pneumothorax. Wound care: keep dry for 1-2 weeks. Activity restriction: limited arm movement (2-4 weeks, prevent lead dislodgement). Follow-up: 1 week, 1 month, then every 6-12 months.

Programming and Follow-Up

Initial Programming

Base rate: 60 bpm (typical, adjustable). Upper rate: 120-130 bpm (prevents tracking rapid atrial rates). Output: 2x threshold (safety margin). Sensitivity: standard values, adjusted based on EGM. Rate response: tuned to patient activity level.

Remote Monitoring

Wireless transmission: device data sent to clinic via home monitor. Frequency: daily or weekly automatic transmissions. Alerts: immediate notification for critical events (lead fracture, arrhythmia). Benefit: reduces in-office visits, earlier detection of problems. Adoption: standard of care for most new implants.

Diagnostics

Pacing percentage: how often device paces (high burden may indicate disease progression). Arrhythmia logs: stored electrograms of detected episodes. Lead trends: impedance, threshold changes over time. Activity level: patient movement data. Heart failure monitoring: intrathoracic impedance (fluid accumulation).

Complications and Management

Infection

Incidence: 1-3% (higher for generator replacements). Organisms: Staphylococcus epidermidis (most common), S. aureus. Treatment: complete system extraction + IV antibiotics. Prevention: sterile technique, prophylactic antibiotics. Re-implantation: opposite side after infection clearance.

Lead-Related Complications

Dislodgement: 2-3% (higher for atrial leads). Perforation: <1% (can cause tamponade). Fracture: 1-2% over 10 years. Insulation failure: increases with age. Extraction: complex procedure if lead removal needed (specialized centers).

Pacemaker Syndrome

Cause: loss of AV synchrony during VVI pacing. Symptoms: fatigue, dizziness, pulsation in neck (cannon A waves). Mechanism: atrial contraction against closed AV valve. Treatment: upgrade to dual-chamber pacing (restore AV synchrony).

Electromagnetic Interference

MRI: conditional devices now available (specific protocols required). Electrocautery: inhibits pacing (reprogram before surgery). Airport security: usually safe (walk through, don't linger). Cell phones: keep >6 inches from device. Household: most appliances safe (avoid strong magnets near device).

Advanced Pacing Technologies

Leadless Pacemakers

Micra (Medtronic): self-contained unit implanted directly in right ventricle. Size: 1 cm³ (10x smaller than conventional). Delivery: catheter through femoral vein. Advantage: no leads (eliminates lead complications), no pocket (no infection risk). Limitation: single-chamber only (VVI), no atrial pacing. Battery: ~12 years.

His Bundle Pacing

Concept: pace the His bundle directly (physiologic activation). Advantage: preserves normal conduction pattern (narrow QRS). Challenge: higher thresholds, technical difficulty. Application: alternative to RV apical pacing (avoids pacing-induced cardiomyopathy). Status: growing adoption.

Conduction System Pacing

Left bundle branch area pacing (LBBAP): emerging technique. Electrode: positioned in interventricular septum near left bundle. Advantage: physiologic activation like His pacing, more stable position. Evidence: promising early results for CRT alternative.

Biological Pacemakers

Gene therapy: reprogram cardiac cells to become pacemaker cells. Stem cells: differentiate into pacemaker-like cells. Status: preclinical research. Promise: biological pacemaker could eliminate need for electronic device. Challenge: long-term stability, safety, regulatory pathway.

References

• Epstein, A. E., DiMarco, J. P., et al. "ACC/AHA/HRS Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities." Circulation, vol. 127, no. 3, 2013, pp. e283-e352.
• Ellenbogen, K. A., Wilkoff, B. L., Kay, G. N., and Lau, C. P. "Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy." Elsevier, 5th ed., 2017.
• Reddy, V. Y., Knops, R. E., Sperzel, J., et al. "Permanent Leadless Cardiac Pacing: Results of the LEADLESS Trial." Circulation, vol. 129, no. 14, 2014, pp. 1466-1471.
• Vijayaraman, P., and Ellenbogen, K. A. "Approach to Permanent His Bundle Pacing." Journal of the American College of Cardiology, vol. 74, no. 18, 2019, pp. 2313-2320.
• Mond, H. G., and Proclemer, A. "The 11th World Survey of Cardiac Pacing." Pacing and Clinical Electrophysiology, vol. 34, no. 8, 2011, pp. 1013-1027.